What is DSGN's dilution risk score?

DSGN has a latest available DilutionScore record of 29/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for DSGN, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for DSGN?

DilutionWatch tracks 25 SEC filing types for DSGN including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect DSGN shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For DSGN, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for DSGN tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for DSGN. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

DSGN Dilution Risk Score: 29/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

0

📊 Float Risk

45

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for DSGN.

🔔 Track DSGN — Get forecast alerts →

Market Data

Market Cap$654.55M

Shares Outstanding62.58M

Float35.36M

Cash$207.40M

Debt$2.73M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 13.7% shares (2026Q1 vs prior)

125 institutional holders · 44.06M shares

#1 SR One Capital Management, LP 6.53M shares

#2 Vivo Capital, LLC 3.23M shares

#3 RA CAPITAL MANAGEMENT, L.P. 2.97M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.95M

Days to Cover12.0

% of Float16.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual DSGN Dilution Snapshot

Design Therapeutics, Inc. (DSGN) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for DSGN: xbrl on 2021-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.